MyMD Pharmaceuticals | D: Filing D
MyMD Pharmaceuticals | D: Filing D
MyMD Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-PharmaCyte Biotech, Inc.(83.4%)
MyMD Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-10% Owner PharmaCyte Biotech, Inc.
MyMD Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Glass Mitchell
MyMD Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Global X Management Company LLC(6.11%)
MyMD Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Iroquois Capital Management L.L.C.(4.99%),Richard Abbe(4.99%), etc.
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Rivard Paul
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Rivard Paul
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chapman Christopher C JR
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kaplin Adam
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Uzonwanne Jude
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Schreiber Christopher C
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director EAGLE CRAIG
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director White Billy Joe
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chapman Christopher C JR
MyMD Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Richard Abbe(6.47%),Iroquois Capital Management L.L.C.(2.85%), etc.
MyMD Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities
MyMD Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Samuel Duffey, Individually(5.86%)
MyMD Pharmaceuticals | D: Filing D
No Data